Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Mink Therapeutics Inc (INKT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Mink Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.31 +0.20    +9.48%
10:30:16 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 16,361
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 2.11 - 2.33
Mink Therapeutics 2.31 +0.20 +9.48%

INKT Technical Analysis

 
A brief summary - strong Buy, Buy, strong Sell, Sell or Neutral signals for the Mink Therapeutics Inc stock. A detailed technical analysis through moving averages buy/sell signals (simple and exponential for 5,10,20,50,100 and 200 periods) and common chart indicators (RSI, Stochastics, StochRSI, MACD, ADX, CCI, ROC, Williams %R, Ultimate and more) Buy, Sell, Overbought, Oversold or Neutral signals. Also - pivot points levels for Standard, Fibonacci, Camarilla, Woodie's and Demark's are supplied. All INKT Stock Technical Studies are available in different time frames.
Summary:Strong Buy
Moving Averages:Strong BuyBuy (10)Sell (2)
Technical Indicators:Strong BuyBuy (6)Sell (2)

Pivot PointsOct 03, 2022 02:36PM GMT

Name S3 S2 S1 Pivot Points R1 R2 R3
Classic 1.81 1.96 2.03 2.18 2.25 2.40 2.47
Fibonacci 1.96 2.04 2.10 2.18 2.26 2.32 2.40
Camarilla 2.05 2.07 2.09 2.18 2.13 2.15 2.17
Woodie's 1.77 1.94 1.99 2.16 2.21 2.38 2.43
DeMark's - - 2.00 2.17 2.22 - -

Technical IndicatorsOct 03, 2022 02:36PM GMT

Name Value Action
RSI(14) 59.540 Buy
STOCH(9,6) 45.134 Neutral
STOCHRSI(14) 90.272 Overbought
MACD(12,26) 0.030 Buy
ADX(14) 26.799 Sell
Williams %R -5.882 Overbought
CCI(14) 189.6237 Buy
ATR(14) 0.1207 High Volatility
Highs/Lows(14) 0.1164 Buy
Ultimate Oscillator 48.847 Sell
ROC 10.526 Buy
Bull/Bear Power(13) 0.3180 Buy

Buy: 6

Sell: 2

Neutral: 1


Summary:Strong Buy

Moving AveragesOct 03, 2022 02:36PM GMT

Period Simple Exponential
MA5 2.17
Buy
2.18
Buy
MA10 2.15
Buy
2.16
Buy
MA20 2.11
Buy
2.13
Buy
MA50 2.08
Buy
2.16
Buy
MA100 2.32
Sell
2.25
Buy
MA200 2.43
Sell
2.23
Buy

Buy: 10

Sell: 2


Summary:Strong Buy

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

INKT Comments

Write your thoughts about Mink Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email